EyePoint Pharmaceuticals Inc. buy Chardan Capital
Start price
28.06.24
/
50%
€8.25
Target price
28.06.25
€26.15
Performance (%)
14.88%
Price
12.07.24
€9.48
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 14.88%. This prediction currently runs until 28.06.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
EyePoint Pharmaceuticals Inc. | 20.955% |
iShares Core DAX® | 1.776% |
iShares Nasdaq 100 | -1.037% |
iShares Nikkei 225® | -0.335% |
iShares S&P 500 | 0.854% |
Comments by Chardan_Capital for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€25.98
07.05.25
07.05.25
-4.42%
12.07.24
12.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
03.08.23
03.08.23
€20.11
03.08.24
03.08.24
-16.58%
12.07.24
12.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.92
03.03.23
03.03.23
€19.79
03.03.24
03.03.24
797.26%
04.03.24
04.03.24